Differential gene expression in human brain pericytes induced by amyloid‐β protein
Abstract
Cerebral amyloid angiopathy is one of the characteristics of Alzheimer's disease (AD) and this accumulation of fibrillar amyloid-beta (Alphabeta) in the vascular wall is accompanied by marked vascular damage. In vitro, Abeta1-40 carrying the 'Dutch' mutation (DAbeta1-40) induces degeneration of cultured human brain pericytes (HBP). To identify possible intracellular mediators of Abeta-induced cell death, a comparative cDNA expression array was performed to detect differential gene expression of Abeta-treated vs. untreated HBP. Messenger RNA expression of cyclin D1, integrin beta4, defender against cell death-1, neuroleukin, thymosin beta10, and integrin alpha5 were increased in DAbeta1-40-treated HBP, whereas insulin-like growth factor binding protein-2 mRNA expression was decreased. Corresponding protein expression was investigated in AD and control brains to explore a potential role for these proteins in pathological lesions of the AD brain. Cyclin D1 expression was increased in cerebral amyloid angiopathy and cells in a perivascular position, suggesting that the cell cycle may be disturbed during Abeta-mediated degeneration of cerebrovascular cells. Moreover, cyclin D1 expression, but also that of integrin beta4, defender against cell death-1, neuroleukin and thymosin beta10 was found in a subset of senile plaques, suggesting a role for these proteins in the pathogenesis of senile plaques.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Messenger RNA levels of NLK are increased in cultured human brain pericytes after exposure to Aβ40.
“messenger RNA levels of NLK were increased in cultured human brain pericytes after exposure to Aβ40 [8]”
From Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy (2021) · cites this paper as [8]
NLK is present in senile plaques and Aβ-laden vessels in AD.
“NLK expression was found in senile plaques and in Aβ-laden vessels [8]”
From Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy (2021) · cites this paper as [8]
The increase in NLK mRNA in cultured human brain pericytes after exposure to Aβ40 may represent an attempt to survive Aβ-induced cell death.
“which may represent an attempt to survive Aβ-induced cell death”
From Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy (2021) · cites this paper as [8]
In an immunohistochemical study in AD patients, NLK expression was found in neurons, microglia, and oligodendroglia, and in the vessel wall, specifically in cerebrovascular cells such as smooth muscle cells.
“In an immunohistochemical study in AD patients, NLK expression was found in neurons, microglia, and oligodendroglia, and in the vessel wall, specifically in cerebrovascular cells such as smooth muscle cells [8].”
From Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy (2021) · cites this paper as [8]
We previously demonstrated by immunohistochemistry that NLK may be associated with CAA pathology.
“We previously demonstrated by immunohistochemistry that NLK may be associated with CAA pathology [8], but apparently this association is not reflected by an increase of NLK in the CSF.”
From Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy (2021) · cites this paper as [8]
Cites
Perry, G., Friedman, R., Shaw, G., & Chau, V (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3033 · Cited by 623 · see citing works
Wisniewski, H. M., Wegiel, J., Wang, K. C., & Lach, B. (1992) · Acta Neuropathologica · doi:10.1007/bf00311383 · Cited by 221 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
De Kort, A. M., Kuiperij, H. B., Alcolea, D., Kersten, I., Versleijen, A. A. M., Greenberg, S. M., Stoops, E., Schreuder, F. H. B. M., Klijn, C. J. M., Lleó, A., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00899-0 · Cited by 13 · see citing works
Self-citation
- Authors
- Rensink, A. A. M., Otte‐Höller, I., Donkelaar, H. J. T., De Waal, R. M. W., Kremer, B., & Verbeek, M. M.
- Corresponding author
- Verbeek, M. M.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2004-02-06
- Volume
- 30
- Issue
- 3
- Pages
- 279-291
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- OpenAlex
- W2021956333
- Cited by
- 24
- References
- 2
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropathology and Applied Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Barbara Ann Karmanos Cancer Institute
- Chinese Academy of Agricultural Sciences
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, cerebral amyloid angiopathy, Alzheimer's disease, differential gene expression, pericyte degeneration, cyclin D1, ITGB4, neuroleukin, integrin alpha5, IGFBP-2, amyloid plaques, perivascular cells, cell cycle
- MeSH terms
- Alzheimer Disease, Brain Chemistry, Cells, Cultured, Cerebral Cortex, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Nerve Tissue Proteins, Gene Expression, Amyloid beta-Peptides, DNA, Complementary, Pericytes, Oligonucleotide Array Sequence Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review